Nicotinamide nucleotide transhydrogenase mutation analysis in Chinese patients with thyroid dysgenesis

Miaomiao Li1, Weibing Tian2, Fengqi Wang1

  • 1The Affiliated Hospital of Qingdao University, Medical Genetic Department, Prenatal Diagnosis Center, Qingdao, China.

Insights

Mutations in the Nicotinamide nucleotide transhydrogenase (NNT) gene are linked to thyroid dysgenesis (TD), a common cause of congenital hypothyroidism. This study identified three new NNT mutations, highlighting NNT

Area of Science:

  • Endocrinology and Genetics
  • Molecular Biology and Cellular Physiology

Background:

  • Thyroid dysgenesis (TD) is the primary cause of congenital hypothyroidism, a prevalent neonatal disorder, accounting for 80% of cases.
  • Current genetic explanations for TD are limited, identifying causative mutations in only 5% of patients, indicating significant genetic heterogeneity.
  • Nicotinamide nucleotide transhydrogenase (NNT) is crucial for redox homeostasis, and its mutations are associated with hypothyroidism, suggesting a potential role in syndromic TD.

Purpose of the Study:

  • To investigate the involvement of the Nicotinamide nucleotide transhydrogenase (NNT) gene in syndromic thyroid dysgenesis (TD).
  • To identify novel causative mutations in the NNT gene within a cohort of TD patients.
  • To functionally characterize the identified NNT mutations and assess their impact on cellular redox balance and thyroid function.

Main Methods:

  • Target sequencing (TS) and Sanger sequencing were employed to screen for NNT gene mutations in 289 TD patients.
  • Functional analyses included western blotting, measurement of NADPH/NADP(total) and H2O2 levels, cell proliferation assays, and wound healing assays.
  • These methods were used to evaluate the effects of identified NNT mutations on protein stability, enzyme activity, and cellular redox state.

Main Results:

  • Three potentially pathogenic mutations in the NNT gene (c.811G>A, p.Ala271Ser; c.2078G>A, p.Arg693His; and c.2581G>A, p.Val861Met) were identified in TD patients.
  • The identified NNT mutations demonstrated detrimental effects on protein stability and catalytic activity.
  • Functional assays revealed that these mutations disrupt the cellular redox balance, impacting key cellular processes.

Conclusions:

  • The study identifies NNT as a novel candidate gene implicated in the pathophysiology of thyroid dysgenesis.
  • The findings expand the spectrum of known genetic factors contributing to TD and congenital hypothyroidism.
  • Further research is warranted to elucidate the precise pathogenic mechanisms through which NNT mutations contribute to TD.